Condition: Optic Neuritis · Myelitis · Myelitis, Transverse · Sponsor: Mayo Clinic
The purpose of this research is to evaluate if early vs rescue Therapeutic Plasma Exchange (PLEX) treatment algorithm leads to better visual outcomes in severe Optic Neuritis and leads to better neurological disability outcomes in severe Transverse Myelitis.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Mayo Clinic Arizona | Scottsdale, Arizona, United States | Recruiting |
| Loma Linda University | Loma Linda, California, United States | Active Not Recruiting |
| University of California, Davis | Sacramento, California, United States | Recruiting |
| University of Colorado - Anschutz Medical | Aurora, Colorado, United States | Recruiting |
| Yale University School of Medicine | North Haven, Connecticut, United States | Recruiting |
| Mayo Clinic Florida | Jacksonville, Florida, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| University of Illinois Chicago | Chicago, Illinois, United States | Recruiting |
| Northwestern University | Evanston, Illinois, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| University of Maryland, Baltimore | Baltimore, Maryland, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
+ 21 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07100990